Patent expiry and costs for anti-cancer medicines for clinical use : expiry and costs anti-cancer medicines

Godman, Brian and Wild, Claudia and Haycox, Alan (2017) Patent expiry and costs for anti-cancer medicines for clinical use : expiry and costs anti-cancer medicines. Generics and Biosimilars Initiative journal. pp. 1-3. ISSN 2033-6772 (In Press)

[thumbnail of Godman-etal-GABI-2017-Patent-expiry-and-costs-for-anti-cancer-medicines-for-clinical]
Preview
 Text. Filename: Godman_etal_GABI_2017_Patent_expiry_and_costs_for_anti_cancer_medicines_for_clinical.pdf
Accepted Author Manuscript
Download (235kB)| Preview

Abstract

Drs Brian Godman, Claudia Wild and Alan Haycox review the paper by Venkatesan et al on the patent expiry of (non-) tyrosine kinase inhibitors.

CORE (COnnecting REpositories)